• March 7, 2026



Choice Institutional Equities is bullish on Senores Pharma has recommended buy rating on the stock with a target price of Rs 1045 in its research report dated January 21, 2026.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

Budget 2026: Agriculture Sector Eyes Tech Push, Rural Credit Reform And More | India News

Forex reserves increase by $392 million to $687.19 billion

Related Posts

UK equities are delivering great diversification

By  

Why Ozak AI Is Dominating the October 2025 Leaderboard

By  

Fidelity debuts pair of active CLO ETFs as investor appetite broadens

By  

How to replicate big super investment strategy for your SMSF using ETFs

By